{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:40:04Z","timestamp":1780634404185,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00277-018-3278-9","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T14:04:39Z","timestamp":1518876279000},"page":"1049-1056","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Enlarged spleen is associated with low neutrophil and platelet engraftment rates and poor survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome"],"prefix":"10.1007","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1018-9508","authenticated-orcid":false,"given":"Yoshimitsu","family":"Shimomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"3278_CR1","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1111\/j.1399-0012.2010.01324.x","volume":"25","author":"M Remberger","year":"2011","unstructured":"Remberger M, Mattsson J, Olsson R, Ringd\u00e9n O (2011) Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure. Clin Transpl 25:E68\u2013E76. https:\/\/doi.org\/10.1111\/j.1399-0012.2010.01324.x","journal-title":"Clin Transpl"},{"key":"3278_CR2","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/leu.2015.75","volume":"29","author":"RF Olsson","year":"2015","unstructured":"Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, Bredeson CN, Dvorak CC, Gupta V, Ho VT, Lazarus HM, Marks DI, Ringd\u00e9n OTH, Pasquini MC, Schriber JR, Cooke KR (2015) Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia 29:1754\u20131762. https:\/\/doi.org\/10.1038\/leu.2015.75","journal-title":"Leukemia"},{"key":"3278_CR3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.bbmt.2010.02.013","volume":"16","author":"J Schriber","year":"2010","unstructured":"Schriber J, Agovi M-A, Ho V, Ballen KK, Bacigalupo A, Lazarus HM, Bredeson CN, Gupta V, Maziarz RT, Hale GA, Litzow MR, Logan B, Bornhauser M, Giller RH, Isola L, Marks DI, Rizzo JD, Pasquini MC (2010) Second unrelated donor hematopoietic cell transplantation for primary graft failure. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 16:1099\u20131106. https:\/\/doi.org\/10.1016\/j.bbmt.2010.02.013","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"3278_CR4","first-page":"247","volume":"5","author":"G Helenglass","year":"1990","unstructured":"Helenglass G, Treleaven J, Parikh P, Aboud H, Smith C, Powles R (1990) Delayed engraftment associated with splenomegaly in patients undergoing bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 5:247\u2013251","journal-title":"Bone Marrow Transplant"},{"key":"3278_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/bmt.2009.188","volume":"45","author":"A Bacigalupo","year":"2010","unstructured":"Bacigalupo A, Soraru M, Dominietto A, Pozzi S, Geroldi S, van Lint MT, Ibatici A, Raiola AM, Frassoni F, de Stefano F, Verdiani S, Casarino L, Barosi G (2010) Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type. Bone Marrow Transplant 45:458\u2013463. https:\/\/doi.org\/10.1038\/bmt.2009.188","journal-title":"Bone Marrow Transplant"},{"key":"3278_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clml.2016.02.004","volume":"16","author":"U Gergis","year":"2016","unstructured":"Gergis U, Kuriakose E, Shore T, Mayer S, Mark T, Pearse R, Schuster M, Feldman E, Roboz G, Ritchie E, Scandura J, Wang H, Zhou XK, Silver RT, van Besien K (2016) Allogeneic transplantation for patients with advanced myelofibrosis: splenomegaly and high serum LDH are adverse risk factors for successful engraftment. Clin Lymphoma Myeloma Leuk 16:297\u2013303. https:\/\/doi.org\/10.1016\/j.clml.2016.02.004","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"3278_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12185-016-2050-y","volume":"104","author":"M-K Song","year":"2016","unstructured":"Song M-K, Chung J-S, Lim S-N, Lee GW, Lee SM, Lee NK, Choi JC, Oh SY (2016) Usefulness of spleen volume measured by computed tomography for predicting clinical outcome in primary myelofibrosis. Int J Hematol 104:476\u2013484. https:\/\/doi.org\/10.1007\/s12185-016-2050-y","journal-title":"Int J Hematol"},{"key":"3278_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B (2009) Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 15:367\u2013369. https:\/\/doi.org\/10.1016\/j.bbmt.2008.12.497","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"3278_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/107327481101800404","volume":"18","author":"M Hamadani","year":"2011","unstructured":"Hamadani M, Mohty M, Kharfan-Dabaja MA (2011) Reduced-intensity conditioning allogeneic hematopoietic cell transplantation in adults with acute myeloid leukemia. Cancer Control J Moffitt Cancer Cent 18:237\u2013245","journal-title":"Cancer Control J Moffitt Cancer Cent"},{"key":"3278_CR10","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M (2009) Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 15:1628\u20131633. https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.004","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"3278_CR11","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3324\/haematol.2016.146811","volume":"101","author":"C Hart","year":"2016","unstructured":"Hart C, Klatt S, Barop J, M\u00fcller G, Schelker R, Holler E, Huber E, Herr W, Grassinger J (2016) Splenic pooling and loss of VCAM-1 causes an engraftment defect in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation. Haematologica 101:1407\u20131416. https:\/\/doi.org\/10.3324\/haematol.2016.146811","journal-title":"Haematologica"},{"key":"3278_CR12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3324\/haematol.2014.109280","volume":"99","author":"A Ruggeri","year":"2014","unstructured":"Ruggeri A, Labopin M, Sormani MP, Sanz G, Sanz J, Volt F, Michel G, Locatelli F, Diaz de Heredia C, O'Brien T, Arcese W, Iori AP, Querol S, Kogler G, Lecchi L, Pouthier F, Garnier F, Navarrete C, Baudoux E, Fernandes J, Kenzey C, Eapen M, Gluckman E, Rocha V, Saccardi R, Eurocord, Cord Blood Committee EBMT, Netcord (2014) Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen. Haematologica 99:1509\u20131515. https:\/\/doi.org\/10.3324\/haematol.2014.109280","journal-title":"Haematologica"},{"key":"3278_CR13","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1182\/blood.V96.13.4096","volume":"96","author":"SM Davies","year":"2000","unstructured":"Davies SM, Kollman C, Anasetti C, Antin JH, Gajewski J, Casper JT, Nademanee A, Noreen H, King R, Confer D, Kernan NA (2000) Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood 96:4096\u20134102","journal-title":"Blood"},{"key":"3278_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers MED, Lilleby K, Chauncey TR, Storb R, Blume K, Heimfeld S, Rowley S, Appelbaum FR (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344:175\u2013181. https:\/\/doi.org\/10.1056\/NEJM200101183440303","journal-title":"N Engl J Med"},{"key":"3278_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/bmt.2012.249","volume":"48","author":"G Akpek","year":"2013","unstructured":"Akpek G, Pasquini MC, Logan B et al (2013) Effects of spleen status on early outcomes after hematopoietic cell transplantation. Bone Marrow Transplant 48:825\u2013831. https:\/\/doi.org\/10.1038\/bmt.2012.249","journal-title":"Bone Marrow Transplant"},{"key":"3278_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jjcc.2015.08.021","volume":"67","author":"M Hara","year":"2016","unstructured":"Hara M, Sakata Y, Nakatani D, Suna S, Nishino M, Sato H, Kitamura T, Nanto S, Hamasaki T, Hori M, Komuro I, OACIS Investigators (2016) Subclinical elevation of high-sensitive troponin T levels at the convalescent stage is associated with increased 5-year mortality after ST-elevation myocardial infarction. J Cardiol 67:314\u2013320. https:\/\/doi.org\/10.1016\/j.jjcc.2015.08.021","journal-title":"J Cardiol"},{"key":"3278_CR17","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1056\/NEJMoa041469","volume":"351","author":"V Rocha","year":"2004","unstructured":"Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E, Acute Leukemia Working Party of European Blood and Marrow Transplant Group, Eurocord-Netcord Registry (2004) Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351:2276\u20132285. https:\/\/doi.org\/10.1056\/NEJMoa041469","journal-title":"N Engl J Med"},{"key":"3278_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1200\/JCO.2000.18.3.537","volume":"18","author":"D Blaise","year":"2000","unstructured":"Blaise D, Kuentz M, Fortanier C, Bourhis JH, Milpied N, Sutton L, Jouet JP, Attal M, Bordigoni P, Cahn JY, Boiron JM, Schuller MP, Moatti JP, Michallet M (2000) Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle. J Clin Oncol Off J Am Soc Clin Oncol 18:537\u2013546. https:\/\/doi.org\/10.1200\/jco.2000.18.3.537","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3278_CR19","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1046\/j.1365-2141.2003.04364.x","volume":"121","author":"O Ringd\u00e9n","year":"2003","unstructured":"Ringd\u00e9n O, Barrett AJ, Zhang M-J et al (2003) Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. Br J Haematol 121:874\u2013885","journal-title":"Br J Haematol"},{"key":"3278_CR20","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1182\/blood-2009-07-231068","volume":"115","author":"JN Barker","year":"2010","unstructured":"Barker JN, Scaradavou A, Stevens CE (2010) Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood 115:1843\u20131849. https:\/\/doi.org\/10.1182\/blood-2009-07-231068","journal-title":"Blood"},{"key":"3278_CR21","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1182\/blood-2005-08-3372","volume":"107","author":"J Delgado","year":"2006","unstructured":"Delgado J, Thomson K, Russell N, Ewing J, Stewart W, Cook G, Devereux S, Lovell R, Chopra R, Marks DI, Mackinnon S, Milligan DW, British Society of Blood and Marrow Transplantation (2006) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study. Blood 107:1724\u20131730. https:\/\/doi.org\/10.1182\/blood-2005-08-3372","journal-title":"Blood"},{"key":"3278_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1600-0609.1983.tb01451.x","volume":"30","author":"C Rohrer","year":"1983","unstructured":"Rohrer C, Arni U, Deubelbeiss KA (1983) Influence of the spleen on the distribution of blood neutrophils. Quantitative studies in the rat. Scand J Haematol 30:103\u2013109","journal-title":"Scand J Haematol"},{"key":"3278_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1620\/tjem.228.295","volume":"228","author":"T Ito","year":"2012","unstructured":"Ito T, Akagi K, Kondo T, Kawabata H, Ichinohe T, Takaori-Kondo A (2012) Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly. Tohoku J Exp Med 228:295\u2013299","journal-title":"Tohoku J Exp Med"},{"key":"3278_CR24","doi-asserted-by":"publisher","first-page":"8751329","DOI":"10.1155\/2016\/8751329","volume":"2016","author":"E Matsubara","year":"2016","unstructured":"Matsubara E, Yamanouchi J, Kitazawa R, Azuma T, Fujiwara H, Hato T, Yasukawa M (2016) Usefulness of low-dose splenic irradiation prior to reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in elderly patients with myelofibrosis. Case Rep Hematol 2016:8751329\u20138751326. https:\/\/doi.org\/10.1155\/2016\/8751329","journal-title":"Case Rep Hematol"},{"key":"3278_CR25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s00277-016-2638-6","volume":"95","author":"A Gratwohl","year":"2016","unstructured":"Gratwohl A, Iacobelli S, Bootsman N et al (2016) Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study. Ann Hematol 95:967\u2013972. https:\/\/doi.org\/10.1007\/s00277-016-2638-6","journal-title":"Ann Hematol"},{"key":"3278_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2141.2010.08417.x","volume":"152","author":"M Robin","year":"2011","unstructured":"Robin M, Tabrizi R, Mohty M, Furst S, Michallet M, Bay JO, Cahn JY, de Coninck E, Dhedin N, Bernard M, Rio B, Buzyn A, Huynh A, Bilger K, Bordigoni P, Contentin N, Porcher R, Soci\u00e9 G, Milpied N (2011) Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC). Br J Haematol 152:331\u2013339. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08417.x","journal-title":"Br J Haematol"},{"key":"3278_CR27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbmt.2017.03.002","volume":"23","author":"M Robin","year":"2017","unstructured":"Robin M, Zine M, Chevret S, Meignin V, Munoz-Bongrand N, Moatti H, Xhaard A, Sicre de Fontbrune F, Peffault de Latour R, Sarfati E, Soci\u00e9 G (2017) The impact of splenectomy in myelofibrosis patients prior to allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 23:958\u2013964. https:\/\/doi.org\/10.1016\/j.bbmt.2017.03.002","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"2","key":"3278_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-2141.1998.00998.x","volume":"103","author":"MA Elliott","year":"1998","unstructured":"Elliott MA, Chen MG, Silverstein MN, Tefferi A (1998) Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia. Br J Haematol 103(2):505\u2013511","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3278-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T07:49:55Z","timestamp":1603871395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3278-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3278"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3278-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"16 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol complied with the Helsinki Declaration standards and was approved by the Ethical Committee of our institutions (Approval No. zn161209 at Kobe City Hospital Organization, Kobe City Medical Center General Hospital and No. 16\u201322 at Foundation for Biomedical Research and Innovation).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}